Article ; Online: Lessons from STIMULI: who benefits from consolidation nivolumab and ipilimumab in limited-disease small-cell lung cancer after chemo-radiotherapy?
2022 Volume 11, Issue 9, Page(s) 3028–3031
MeSH term(s) | Chemoradiotherapy ; Humans ; Ipilimumab/therapeutic use ; Lung Neoplasms/drug therapy ; Nivolumab/therapeutic use ; Small Cell Lung Carcinoma/drug therapy ; Small Cell Lung Carcinoma/radiotherapy |
---|---|
Chemical Substances | Ipilimumab ; Nivolumab (31YO63LBSN) |
Language | English |
Publishing date | 2022-08-11 |
Publishing country | China |
Document type | Journal Article |
ZDB-ID | 2828544-X |
ISSN | 2224-5839 ; 2224-5839 |
ISSN (online) | 2224-5839 |
ISSN | 2224-5839 |
DOI | 10.21037/apm-22-857 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.